Innovation, Commercialization, and Start-Ups in Life Sciences

Innovation, Commercialization, and Start-Ups in Life Sciences

by James F. Jordan
Released November 2014
Publisher(s): CRC Press
ISBN: 9781482210132

Read it now on the O’Reilly learning platform with a 10-day free trial.

O’Reilly members get unlimited access to books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.

Start your free trial

Book description

Innovation is the translation of a new method, idea, or product into reality and profit. It is a process of connected steps that accumulates into your brand or reputation. However, there can be many pitfalls and wrong turns on the road to realizing this goal. Innovation, Commercialization, and Start-Ups in Life Sciences details the methodologies necessary to create a successful life sciences start-up from initiation to exit. You will gain an appreciation for the necessary data, partnership, and skills to be acquired and the constituencies that must be satisfied along the way.

The book examines how life sciences start-ups can create an exit for their investors by recognizing that a liquidity event is not consummated without due diligence. Due diligence is bigger than validating accounting transactions. It ensures the company is solving an important customer problem, demonstrating sales access, and making sure that intellectual property is impervious to competitive advancement. The due diligence process supports the telling of a compelling story to customers, investors, regulators, and acquirers.

Written by an expert who has worked with more than 200 life sciences start-ups during the past decade, the book discusses specific processes and investor milestones that must be navigated to align customer, funder, and acquirer needs. It examines these processes from the perspective of marketing value through a focus on the needs of individual constituents—investors, regulators, customers, and exit candidates. The book presents data and analytical processes articulating the fundable milestones for angel and venture capital. It gives you the tools needed to create branding for public investors and more.

Table of contents

  1. Front Cover (1/2)
  2. Front Cover (2/2)
  3. Contents (1/2)
  4. Contents (2/2)
  5. Foreword
  6. Acknowledgments (1/2)
  7. Acknowledgments (2/2)
  8. The Book’s Web Sites
  9. Chapter 1: Investment Uses a Translation Process to Deliver Innovation (1/2)
  10. Chapter 1: Investment Uses a Translation Process to Deliver Innovation (2/2)
  11. Chapter 2: Investment Is Critical to a Nation’s Prosperity
  12. Chapter 3: The Journey of Innovation Begins with Investment (1/2)
  13. Chapter 3: The Journey of Innovation Begins with Investment (2/2)
  14. Chapter 4: The United States Helps Small Companies Conduct R&D (1/2)
  15. Chapter 4: The United States Helps Small Companies Conduct R&D (2/2)
  16. Chapter 5: Commercialization Is Primarily Executed through Two Organization Types (1/2)
  17. Chapter 5: Commercialization Is Primarily Executed through Two Organization Types (2/2)
  18. Chapter 6: Angels and Venture Capitalists Invest in Commercialization (1/4)
  19. Chapter 6: Angels and Venture Capitalists Invest in Commercialization (2/4)
  20. Chapter 6: Angels and Venture Capitalists Invest in Commercialization (3/4)
  21. Chapter 6: Angels and Venture Capitalists Invest in Commercialization (4/4)
  22. Chapter 7: Create Liquidity for Your Investors (1/2)
  23. Chapter 7: Create Liquidity for Your Investors (2/2)
  24. Chapter 8: A Liquidity Event Is Not Consummated without Due Diligence (1/3)
  25. Chapter 8: A Liquidity Event Is Not Consummated without Due Diligence (2/3)
  26. Chapter 8: A Liquidity Event Is Not Consummated without Due Diligence (3/3)
  27. Chapter 9: Due Diligence Reputation Is a Critical Business Process (1/4)
  28. Chapter 9: Due Diligence Reputation Is a Critical Business Process (2/4)
  29. Chapter 9: Due Diligence Reputation Is a Critical Business Process (3/4)
  30. Chapter 9: Due Diligence Reputation Is a Critical Business Process (4/4)
  31. Chapter 10: Find the Industry Norms (1/2)
  32. Chapter 10: Find the Industry Norms (2/2)
  33. Chapter 11: Solve an Important Customer Problem (1/3)
  34. Chapter 11: Solve an Important Customer Problem (2/3)
  35. Chapter 11: Solve an Important Customer Problem (3/3)
  36. Chapter 12: Demonstrate the Ability to Access the Sales Channel (1/2)
  37. Chapter 12: Demonstrate the Ability to Access the Sales Channel (2/2)
  38. Chapter 13: Gather Domain-Experienced Personnel to Reduce Risk (1/7)
  39. Chapter 13: Gather Domain-Experienced Personnel to Reduce Risk (2/7)
  40. Chapter 13: Gather Domain-Experienced Personnel to Reduce Risk (3/7)
  41. Chapter 13: Gather Domain-Experienced Personnel to Reduce Risk (4/7)
  42. Chapter 13: Gather Domain-Experienced Personnel to Reduce Risk (5/7)
  43. Chapter 13: Gather Domain-Experienced Personnel to Reduce Risk (6/7)
  44. Chapter 13: Gather Domain-Experienced Personnel to Reduce Risk (7/7)
  45. Chapter 14: Determine the Acquirer’s Strategic Future and Purchase Triggers (1/3)
  46. Chapter 14: Determine the Acquirer’s Strategic Future and Purchase Triggers (2/3)
  47. Chapter 14: Determine the Acquirer’s Strategic Future and Purchase Triggers (3/3)
  48. Chapter 15: Align an Investor’s Fundable Milestones and an Acquirer’s Exit Points (1/3)
  49. Chapter 15: Align an Investor’s Fundable Milestones and an Acquirer’s Exit Points (2/3)
  50. Chapter 15: Align an Investor’s Fundable Milestones and an Acquirer’s Exit Points (3/3)
  51. Chapter 16: Create an IP Pyramid for Impervious Positioning (1/2)
  52. Chapter 16: Create an IP Pyramid for Impervious Positioning (2/2)
  53. Chapter 17: Address Your Story to the Needs of All Constituencies
  54. Chapter 18: Deliver to Your Plan (1/4)
  55. Chapter 18: Deliver to Your Plan (2/4)
  56. Chapter 18: Deliver to Your Plan (3/4)
  57. Chapter 18: Deliver to Your Plan (4/4)
  58. Chapter 19: Tell a Compelling Story with the Investor Pitch (1/2)
  59. Chapter 19: Tell a Compelling Story with the Investor Pitch (2/2)
  60. Chapter 20: Continuously Improve Your Message with the Plan-Do-Check-Act Cycle
  61. Notes (1/2)
  62. Notes (2/2)
  63. Back Cover

Product information

  • Title: Innovation, Commercialization, and Start-Ups in Life Sciences
  • Author(s): James F. Jordan
  • Release date: November 2014
  • Publisher(s): CRC Press
  • ISBN: 9781482210132